Vetter T R
Department of Anesthesiology, Children's Hospital Medical Center of Akron, OH.
J Clin Anesth. 1993 Jan-Feb;5(1):58-61. doi: 10.1016/0952-8180(93)90090-2.
To validate the superiority of higher-dose oral midazolam as an anesthetic premedicant in children 6 years of age and younger, to determine whether less expensive diazepam is a viable alternative oral premedicant in this age-group, and to assess the preoperative oxygenation effects of both benzodiazepines.
A prospective, randomized, double-blind study.
Outpatient surgery department and operating room (OR) of a freestanding children's hospital.
Seventy-five ASA physical status I and II outpatients 1 to 6 years of age.
Patients were randomized to receive either midazolam 0.6 mg/kg, diazepam 0.3 mg/kg, or a placebo orally in a timely manner prior to surgery.
Each child's subsequent reaction to separation from his or her parents in the presurgical holding area was scored on a three-point behavioral scale. Once in the OR, an initial room air oxygen saturation by pulse oximeter (SpO2) was obtained. Each child's initial acceptance of the anesthetic induction mask was then scored on a four-point scale. No significant differences in parental separation scores, initial room air SpO2, or postanesthesia care unit admission time were observed among the three study groups. However, both midazolam and diazepam were observed to be superior to the placebo in facilitating the initial acceptance of the anesthetic induction mask.
Even without premedication, a majority of children did not react negatively to an impending anesthetic. Therefore, neither midazolam nor diazepam appears to be necessary in most children younger than 6 years of age. Rather than implementing the routine use of an oral preoperative sedative, the challenge appears to be the selective identification of those children at risk for preanesthetic difficulties and psychological trauma.
验证高剂量口服咪达唑仑作为6岁及以下儿童麻醉前用药的优越性,确定成本较低的地西泮是否是该年龄组可行的替代口服术前用药,并评估两种苯二氮䓬类药物的术前氧合作用。
一项前瞻性、随机、双盲研究。
一家独立儿童医院的门诊手术部和手术室(OR)。
75名年龄在1至6岁的美国麻醉医师协会(ASA)身体状况I级和II级门诊患者。
患者被随机分组,在手术前及时口服咪达唑仑0.6mg/kg、地西泮0.3mg/kg或安慰剂。
根据三点行为量表对每个孩子在术前等候区与父母分离后的后续反应进行评分。进入手术室后,通过脉搏血氧仪(SpO2)获得初始室内空气氧饱和度。然后根据四点量表对每个孩子对麻醉诱导面罩的初始接受程度进行评分。在三个研究组中,父母分离评分、初始室内空气SpO2或麻醉后护理单元入院时间均未观察到显著差异。然而,观察到咪达唑仑和地西泮在促进对麻醉诱导面罩的初始接受方面均优于安慰剂。
即使不进行术前用药,大多数儿童对即将进行的麻醉也没有负面反应。因此,对于大多数6岁以下的儿童来说,咪达唑仑和地西泮似乎都没有必要。与其常规使用口服术前镇静剂,挑战似乎在于选择性识别那些有麻醉困难和心理创伤风险的儿童。